Vigabatrin
Limited data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- no dose data
- PubChem toxicity data
- 1 source
- no dose data
- PubChem toxicity data
Summary
Vigabatrin is an antiepileptic (anticonvulsant) medication, sold under the brand name Sabril. It irreversibly inhibits GABA transaminase, raising brain GABA levels, and is used to treat refractory complex partial seizures and infantile spasms. It is not a recreational drug; long-term use carries a risk of permanent peripheral vision loss.
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session — the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Effects
- Physical euphoria
- Muscle relaxation
- Anxiolytic
- Motor impairment
- Nausea
- Respiratory depression
- Sedation
- Sedative
- Dystaxia
- Itchiness
- Reduced anxiety
- Cognitive euphoria
- Anxiety suppression
- Euphoria
- Dizziness
- Compulsive redosing
- Thought deceleration
- Amnesia
- Motor control loss
- Constipation
- Increased music appreciation
- Increased libido
- Disinhibition
- Appetite suppression
- Dehydration
- Light sensitivity
- Double vision
- Acuity suppression
- Dulled perception
- Internal hallucinations
Pill Identifiers
Helpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for Vigabatrin? Let us know. Reports are reviewed by moderators — this is not posted publicly.